search
Back to results

Growing Together: Women in Opioid Treatment and Their Infants

Primary Purpose

Substance-Related Disorders

Status
Unknown status
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
BRIGHT
STAR/TAU+
Sponsored by
Boston University Charles River Campus
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Substance-Related Disorders focused on measuring maternal opioid use, substance use, parent-child relationship, parenting, social and emotional development, mental health and well-being, perinatal, postpartum, health disparities

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • A patient at BUMC RESPECT clinic with history of opioid use or history of polysubstance use
  • 18 years orolder
  • Being treated with methadone, naltrexone, or suboxone
  • In 3rd trimester of pregnancy
  • Deemed by MDs able to give informed consent
  • Planning to parent infant after birth
  • Willing to participate in RCT

Exclusion Criteria:

  • Planning to relinquish custody of neonate
  • Residing, or expected to reside post-birth 20+ miles from Boston
  • Deemed by MDs unable to give informed consent

Sites / Locations

  • Boston Medical CenterRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

BRIGHT

STAR/TAU+

Arm Description

Building Resilience through Intervention: Growing Healthier Together (BRIGHT) weekly home-based intervention from the third trimester of pregnancy through 6 months postpartum. A licensed clinician meets with mother and infant to promote attunement and optimal parent-child interactions. Additionally, the mother receives monthly handouts focused on information about child development and recovery from substance misuse while parenting, along with the standard of care at a high risk maternal-fetal medical clinic

The mother receives monthly handouts focused on information about child development and recovery from substance misuse while parenting, along with the standard of care at a high risk maternal-fetal medical clinic.

Outcomes

Primary Outcome Measures

Coding Interactive Behavior (CIB) system (Observer-rated parent-infant video), measuring Maternal Sensitivity (representing the parent-child relationship)
CIB is a rating of mother-child interactions which has three 5-point Likert subscales: Maternal Sensitivity (MSense, primary outcome), Maternal intrusiveness (MIntrude), and Child involvement. (CInvolve). High scores on CIB scales indicate more evidence of the behavior/dimension. Moderate scores typically indicate presence of the behavior/dimension approximately 50% of the time. Low scores indicate that the behavior/dimension is never/infrequently observed. The CIB has been validated with healthy and at-risk populations. The study is assessing the change in CIB score between the time points.
The Adult- Adolescent Parenting Inventory-2 (AAPI), measuring the Risk of Child Maltreatment
Responses to the inventory provide an index of risk for practicing behaviors known to be attributable to child abuse and neglect. Answers are recorded on a scale from Strongly Agree to Strongly Disagree. Subscales include: Construct A - Inappropriate Expectations of Children, Construct B - Parental Lack of Empathy Towards Children's Needs, Construct C - Strong Parental Belief in the Use of Corporal Punishment, Construct D - Reversing Parent-Child Family Roles, Construct E - Oppressing Children's Power and Independence. 32-item inventory assessing parenting and child-rearing attitudes associated with risk for child maltreatment. Five parenting interaction constructs include, 1) inappropriate expectations for child, 2) empathic awareness of child's needs, 3) belief in corporal punishment, 4) role reversal and 5) oppressing children's power. Construct validity is well-established. Test-re-test reliability is .76. The study is assessing the change in AAPI score between the time points.

Secondary Outcome Measures

Karitane Parenting Confidence Scale (KPCS), measuring Parenting Capacity
15-item self-report measure of perceived parental self-efficacy, for parents of infants birth-12 months .82 The KPCS has good internal validity and test-re-test reliability is .88. Each item on the KPCS is scored 0, 1, 2, or 3, with scores summed to produce a total score. The general rule is that a high score indicates the parent is feeling confident on that item.
Parenting Stress Index/Short Form (PSI/SF), measuring Parenting Capacity
36-item self-report measure of parenting stress in 3 domains: parental distress, parent-child dysfunctional interaction, and parent's perceptions of child's difficulty. A high total stress score (above 90) indicates a greater level of parenting stress. The PSI/SF has excellent external validity, and test-re-test reliability is .76. Screening and triage measure for evaluating the parenting system and identifying issues that may lead to problems in the child's or parent's behavior. Focuses on three major domains of stress: child characteristics, parent characteristics and situational/demographic life stress. 1-5 Likert scale. 3 subscales: Parental Distress, Parent-Child Dysfunctional Interaction, and Difficult Child. Child and Parent domains combine to form Total Stress Scale.
The Parental Reflective Functioning Questionnaire (PRFQ), measuring Parenting Capacity
Multidimensional assessment of parental reflective functioning in parents with children 0-5 years old. 1-7 Likert scale (1= Strongly Disagree, 7= Strongly Agree). 39-item measure of levels of reflective functioning - parent's ability to reflect upon and "see" their child's internal experiences, including wishes, fears, intentions, and emotions that drive children's behavior. Higher levels of reflective functioning indicate abilities to respond in a more empathetic and supportive manner. The PRFQ has good internal consistency and discriminant validity.
The Brief Symptom Inventory (BSI), measuring Maternal Mental Health (including continuation of OUD treatment)
Provides an overview of a patient's psychological symptoms and their intensity at a specific point in time. 0-4 Likert scale, lower scores are "better." 53-item self-report measure of mothers' psychological distress. Dimensions include depression, somatization, obsession-compulsion, anxiety, hostility, phobic anxiety, interpersonal sensitivity, paranoid ideation, and psychoticism. The BSI is known to have good reliability and validity.
The Life Stressor Checklist- Revised (LSC-R), measuring Maternal Mental Health (including continuation of OUD treatment)
22-item, self-report measure of traumatic or stressful life events. Stressful events are rated for occurrence (yes/no) and the age(s) of occurrence. The LSC-R maintains good criterion validity and test-retest reliability. A lower score is "better."
Connor-Davidson Resilience Scale-10 (CD-RISC 10), measuring Maternal Mental Health (including continuation of OUD treatment)
10-item assessment of resilience, specifically hardiness and persistence, has demonstrated strong psychometric properties. CDRS measures "bounce-back" and adaptability in relationship to stress. 0-4 Likert scale (0= Not true at all; 4= True nearly all the time). Higher scores are considered "better."
Post Traumatic Stress Disorder Checklist (PCL-5), measuring Maternal Mental Health (including continuation of OUD treatment)
20-item self-report questionnaire, corresponds to DSM-5 symptom criteria for PTSD. Rating scales span 0-4 for each symptom. The wording of PCL-5 items reflects both changes to existing symptoms and the addition of new symptoms in DSM-5. Preliminary validation work suggests a cut point of 38. 0-4 Likert scale (0= Not at all; 4= Extremely) Lower scores are considered "better."
Addiction Severity Index (ASI), measuring Maternal Mental Health (including continuation of OUD treatment)
Semi-structured interview designed to address misuse of alcohol and drugs in the past 30 days and lifetime use in days and years. Lower numbers are considered "better."
Devereaux Early Childhood Assessment for Infants and Toddlers (DECA-I/T), measuring Infant Social-Emotional Development
Standardized assessment of protective factors and screens for social/emotional risks and development in very young children, has demonstrated very good reliability and validity.89 Parents report perceptions of their child's qualities/abilities, yielding 2 scales: infant initiative and attachment, with an overall protective factors scale. It is recommended as a research tool to assess infants' and toddlers' social-emotional outcomes. 0-4 Likert scale (0= Never, 4= Very Frequently), higher values represent better outcomes
Parent Development Interview (PDI)- Short Form Revised 2016, measuring Parental Reflective Functioning
A semi-structured clinical interview that asks parents to describe the child, their internal experience of parenting, and their experience of the relationship with the child. The PI is coded by a trained and reliable PI coder using the Reflective Functioning Scale. -1 through 9 scale (-1: Negative; 9: Full or Exceptional). Higher scores indicate a high level of reflective functioning sophistication.

Full Information

First Posted
November 20, 2018
Last Updated
July 8, 2020
Sponsor
Boston University Charles River Campus
Collaborators
Health Resources and Services Administration (HRSA), Institute for Health and Recovery (IHR), Boston University, Boston University School of Social Work
search

1. Study Identification

Unique Protocol Identification Number
NCT03866694
Brief Title
Growing Together: Women in Opioid Treatment and Their Infants
Official Title
Growing Together: A Pragmatic Clinical Trial of a Parenting Intervention for Women in Opioid Treatment and Their Infants
Study Type
Interventional

2. Study Status

Record Verification Date
July 2020
Overall Recruitment Status
Unknown status
Study Start Date
December 13, 2018 (Actual)
Primary Completion Date
March 31, 2021 (Anticipated)
Study Completion Date
December 30, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Boston University Charles River Campus
Collaborators
Health Resources and Services Administration (HRSA), Institute for Health and Recovery (IHR), Boston University, Boston University School of Social Work

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study evaluates the effectiveness of the home-based therapeutic parenting intervention BRIGHT with pregnant women and postpartum mothers with opioid use disorders (OUDs) and their infants. It examines whether participation in the BRIGHT intervention improves parent-child relationships, parenting capacities, the mother's overall mental health, participation in OUD treatment, infant social-emotional development and decreases the likelihood of child maltreatment. Approximately half of the participants will receive the BRIGHT intervention, monthly handouts, and the standard of care at the maternal-fetal medical clinic and the other half will receive STAR, or Enhanced Treatment as Usual (TAU+), which includes monthly handouts and the standard of care from the medical clinic.
Detailed Description
Growing Together is a two-armed pragmatic randomized controlled trial of a trauma and evidence-informed therapeutic parenting intervention, BRIGHT. This trial lasts approximately 9 months. BRIGHT has been offered to young children ages birth through 6 years and their parents affected by substance use disorders (SUDs) to mitigate the effects of trauma, promote resilience, and enhance the quality of parent-child relationships and parenting skills. BRIGHT has been successfully piloted and evaluated within residential treatment and outpatient opioid treatment programs for pregnant women/mothers with SUDs and OUDs with young children . For this study, BRIGHT has been adapted for home-based delivery for pregnant women receiving treatment for OUDs and is offered from the 3rd trimester of pregnancy until the infant is about 6 months old. Participants in both arms will be recruited from a high-risk maternal-fetal medicine clinic and followed for approximately 15 months. The two arms of the trial are 1) the BRIGHT (Building Resilience through Intervention, Growing Healthier Together) intervention, and 2) STAR. Both arms of the study will receive the typical standard of care of at a high-risk maternal-fetal medical clinic and 7 monthly psycho-educational handouts on child development specifically for mothers in recovery. The investigators are testing the effectiveness of the adapted version of BRIGHT by utilizing measures to examine if participation in BRIGHT decreases the likelihood of child maltreatment, improves parent-child relationships, parenting capacities, the mother's overall mental health, participation in OUD treatment, and infant social-emotional development.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Substance-Related Disorders
Keywords
maternal opioid use, substance use, parent-child relationship, parenting, social and emotional development, mental health and well-being, perinatal, postpartum, health disparities

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Participants in this randomized controlled trial are assigned to one of two groups, BRIGHT or STAR. BRIGHT is a therapeutic parenting intervention that begins in the third trimester of pregnancy and continues through six months postpartum. BRIGHT and STAR receive the standard of care at a high risk maternal-fetal medical clinic and 7 psycho-educational handouts over the course of the study.
Masking
None (Open Label)
Masking Description
No masking is used in this clinical trial.
Allocation
Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
BRIGHT
Arm Type
Experimental
Arm Description
Building Resilience through Intervention: Growing Healthier Together (BRIGHT) weekly home-based intervention from the third trimester of pregnancy through 6 months postpartum. A licensed clinician meets with mother and infant to promote attunement and optimal parent-child interactions. Additionally, the mother receives monthly handouts focused on information about child development and recovery from substance misuse while parenting, along with the standard of care at a high risk maternal-fetal medical clinic
Arm Title
STAR/TAU+
Arm Type
Active Comparator
Arm Description
The mother receives monthly handouts focused on information about child development and recovery from substance misuse while parenting, along with the standard of care at a high risk maternal-fetal medical clinic.
Intervention Type
Behavioral
Intervention Name(s)
BRIGHT
Intervention Description
Dyadic therapeutic parenting intervention (BRIGHT) beginning in third trimester of pregnancy through six months postpartum focusing on child-parent relationship, mental health, infant social-emotional development, and recovery. Monthly handouts for mothers in recovery with information about child development and recovery from substance misuse while parenting and the standard of care at participant's high risk maternal-fetal medical clinic.
Intervention Type
Other
Intervention Name(s)
STAR/TAU+
Intervention Description
Monthly handouts for mothers in recovery with information about child development and recovery from substance misuse while parenting and the standard of care at participant's high risk maternal-fetal medical clinic
Primary Outcome Measure Information:
Title
Coding Interactive Behavior (CIB) system (Observer-rated parent-infant video), measuring Maternal Sensitivity (representing the parent-child relationship)
Description
CIB is a rating of mother-child interactions which has three 5-point Likert subscales: Maternal Sensitivity (MSense, primary outcome), Maternal intrusiveness (MIntrude), and Child involvement. (CInvolve). High scores on CIB scales indicate more evidence of the behavior/dimension. Moderate scores typically indicate presence of the behavior/dimension approximately 50% of the time. Low scores indicate that the behavior/dimension is never/infrequently observed. The CIB has been validated with healthy and at-risk populations. The study is assessing the change in CIB score between the time points.
Time Frame
t1 (6-8 Weeks postpartum), t2 (6-8 months postpartum)
Title
The Adult- Adolescent Parenting Inventory-2 (AAPI), measuring the Risk of Child Maltreatment
Description
Responses to the inventory provide an index of risk for practicing behaviors known to be attributable to child abuse and neglect. Answers are recorded on a scale from Strongly Agree to Strongly Disagree. Subscales include: Construct A - Inappropriate Expectations of Children, Construct B - Parental Lack of Empathy Towards Children's Needs, Construct C - Strong Parental Belief in the Use of Corporal Punishment, Construct D - Reversing Parent-Child Family Roles, Construct E - Oppressing Children's Power and Independence. 32-item inventory assessing parenting and child-rearing attitudes associated with risk for child maltreatment. Five parenting interaction constructs include, 1) inappropriate expectations for child, 2) empathic awareness of child's needs, 3) belief in corporal punishment, 4) role reversal and 5) oppressing children's power. Construct validity is well-established. Test-re-test reliability is .76. The study is assessing the change in AAPI score between the time points.
Time Frame
t1 (6-8 weeks postpartum), t2 (6-8 months postpartum), t3 (9-11 months postpartum)
Secondary Outcome Measure Information:
Title
Karitane Parenting Confidence Scale (KPCS), measuring Parenting Capacity
Description
15-item self-report measure of perceived parental self-efficacy, for parents of infants birth-12 months .82 The KPCS has good internal validity and test-re-test reliability is .88. Each item on the KPCS is scored 0, 1, 2, or 3, with scores summed to produce a total score. The general rule is that a high score indicates the parent is feeling confident on that item.
Time Frame
t1 (6-8 weeks postpartum), t2 (6-8 months postpartum), t3 (9-11 months postpartum)
Title
Parenting Stress Index/Short Form (PSI/SF), measuring Parenting Capacity
Description
36-item self-report measure of parenting stress in 3 domains: parental distress, parent-child dysfunctional interaction, and parent's perceptions of child's difficulty. A high total stress score (above 90) indicates a greater level of parenting stress. The PSI/SF has excellent external validity, and test-re-test reliability is .76. Screening and triage measure for evaluating the parenting system and identifying issues that may lead to problems in the child's or parent's behavior. Focuses on three major domains of stress: child characteristics, parent characteristics and situational/demographic life stress. 1-5 Likert scale. 3 subscales: Parental Distress, Parent-Child Dysfunctional Interaction, and Difficult Child. Child and Parent domains combine to form Total Stress Scale.
Time Frame
t1 (6-8 weeks postpartum), t2 (6-8 months postpartum), t3 (9-11 months postpartum)
Title
The Parental Reflective Functioning Questionnaire (PRFQ), measuring Parenting Capacity
Description
Multidimensional assessment of parental reflective functioning in parents with children 0-5 years old. 1-7 Likert scale (1= Strongly Disagree, 7= Strongly Agree). 39-item measure of levels of reflective functioning - parent's ability to reflect upon and "see" their child's internal experiences, including wishes, fears, intentions, and emotions that drive children's behavior. Higher levels of reflective functioning indicate abilities to respond in a more empathetic and supportive manner. The PRFQ has good internal consistency and discriminant validity.
Time Frame
t1 (6-8 weeks postpartum), t2 (6-8 months postpartum), t3 (9-11 months postpartum)
Title
The Brief Symptom Inventory (BSI), measuring Maternal Mental Health (including continuation of OUD treatment)
Description
Provides an overview of a patient's psychological symptoms and their intensity at a specific point in time. 0-4 Likert scale, lower scores are "better." 53-item self-report measure of mothers' psychological distress. Dimensions include depression, somatization, obsession-compulsion, anxiety, hostility, phobic anxiety, interpersonal sensitivity, paranoid ideation, and psychoticism. The BSI is known to have good reliability and validity.
Time Frame
t0 (3rd trimester), t1 (6-8 weeks postpartum), t2 (6-8 months postpartum)
Title
The Life Stressor Checklist- Revised (LSC-R), measuring Maternal Mental Health (including continuation of OUD treatment)
Description
22-item, self-report measure of traumatic or stressful life events. Stressful events are rated for occurrence (yes/no) and the age(s) of occurrence. The LSC-R maintains good criterion validity and test-retest reliability. A lower score is "better."
Time Frame
t0 (3rd trimester)
Title
Connor-Davidson Resilience Scale-10 (CD-RISC 10), measuring Maternal Mental Health (including continuation of OUD treatment)
Description
10-item assessment of resilience, specifically hardiness and persistence, has demonstrated strong psychometric properties. CDRS measures "bounce-back" and adaptability in relationship to stress. 0-4 Likert scale (0= Not true at all; 4= True nearly all the time). Higher scores are considered "better."
Time Frame
t0 (3rd trimester), t1 (6-8 weeks postpartum), t2 (6-8 months postpartum)
Title
Post Traumatic Stress Disorder Checklist (PCL-5), measuring Maternal Mental Health (including continuation of OUD treatment)
Description
20-item self-report questionnaire, corresponds to DSM-5 symptom criteria for PTSD. Rating scales span 0-4 for each symptom. The wording of PCL-5 items reflects both changes to existing symptoms and the addition of new symptoms in DSM-5. Preliminary validation work suggests a cut point of 38. 0-4 Likert scale (0= Not at all; 4= Extremely) Lower scores are considered "better."
Time Frame
t0 (3rd trimester), t1 (6-8 weeks postpartum), t2 (6-8 months postpartum)
Title
Addiction Severity Index (ASI), measuring Maternal Mental Health (including continuation of OUD treatment)
Description
Semi-structured interview designed to address misuse of alcohol and drugs in the past 30 days and lifetime use in days and years. Lower numbers are considered "better."
Time Frame
t0 (3rd trimester), t1 (6-8 weeks postpartum), t2 (6-8 months postpartum)
Title
Devereaux Early Childhood Assessment for Infants and Toddlers (DECA-I/T), measuring Infant Social-Emotional Development
Description
Standardized assessment of protective factors and screens for social/emotional risks and development in very young children, has demonstrated very good reliability and validity.89 Parents report perceptions of their child's qualities/abilities, yielding 2 scales: infant initiative and attachment, with an overall protective factors scale. It is recommended as a research tool to assess infants' and toddlers' social-emotional outcomes. 0-4 Likert scale (0= Never, 4= Very Frequently), higher values represent better outcomes
Time Frame
t1 (6-8 weeks postpartum), t2 (6-8 months postpartum), t3 (9-11 months postpartum)
Title
Parent Development Interview (PDI)- Short Form Revised 2016, measuring Parental Reflective Functioning
Description
A semi-structured clinical interview that asks parents to describe the child, their internal experience of parenting, and their experience of the relationship with the child. The PI is coded by a trained and reliable PI coder using the Reflective Functioning Scale. -1 through 9 scale (-1: Negative; 9: Full or Exceptional). Higher scores indicate a high level of reflective functioning sophistication.
Time Frame
t0 (3rd trimester), t2 (6-8 months postpartum)

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: A patient at BUMC RESPECT clinic with history of opioid use or history of polysubstance use 18 years orolder Being treated with methadone, naltrexone, or suboxone In 3rd trimester of pregnancy Deemed by MDs able to give informed consent Planning to parent infant after birth Willing to participate in RCT Exclusion Criteria: Planning to relinquish custody of neonate Residing, or expected to reside post-birth 20+ miles from Boston Deemed by MDs unable to give informed consent
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ashley Short, MSW
Phone
617-358-2368
Email
growrct@bu.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Ruth Paris, PhD
Phone
617-353-7717
Email
rparis@bu.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ruth Paris, PhD
Organizational Affiliation
Boston University School of Social Work
Official's Role
Principal Investigator
Facility Information:
Facility Name
Boston Medical Center
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02118
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ruth Rose-Jacobs, ScD, MS

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Growing Together: Women in Opioid Treatment and Their Infants

We'll reach out to this number within 24 hrs